We are analyzing https://link.springer.com/article/10.1007/s11892-017-0908-x.

Title:
Mechanisms of Type 2 Diabetes Risk Loci | Current Diabetes Reports
Description:
Purpose of Review Deciphering the mechanisms of type 2 diabetes (T2DM) risk loci can greatly inform on disease pathology. This review discusses current knowledge of mechanisms through which genetic variants influence T2DM risk and considerations for future studies. Recent Findings Over 100 T2DM risk loci to date have been identified. Candidate causal variants at risk loci map predominantly to non-coding sequence. Physiological, epigenomic and gene expression data suggest that variants at many known T2DM risk loci affect pancreatic islet regulation, although variants at other loci also affect protein function and regulatory processes in adipose, pre-adipose, liver, skeletal muscle and brain. The effects of T2DM variants on regulatory activity in these tissues appear largely, but not exclusively, due to altered transcription factor binding. Putative target genes of T2DM variants have been defined at an increasing number of loci and some, such as FTO, may entail several genes and multiple tissues. Gene networks in islets and adipocytes have been implicated in T2DM risk, although the molecular pathways of risk genes remain largely undefined. Summary Efforts to fully define the mechanisms of T2DM risk loci are just beginning. Continued identification of risk mechanisms will benefit from combining genetic fine-mapping with detailed phenotypic association data, high-throughput epigenomics data from diabetes-relevant tissue, functional screening of candidate genes and genome editing of cellular and animal models.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Business & Finance
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

pubmed, article, google, scholar, cas, central, diabetes, type, genet, human, loci, variants, genetic, nat, risk, nature, gene, cell, studies, association, gaulton, expression, doinature, analysis, mechanisms, insulin, data, regulatory, genes, doidb, chromatin, causal, pancreatic, genomewide, plos, tdm, susceptibility, common, glucose, locus, disease, islets, functional, genome, science, doijournalpgen, content, islet, regulation, transcription,

Topics {✒️}

genome-wide trans-ancestry meta-analysis int/mediacentre/factsheets/fs312/en/ allele-specific transcriptional activity trans-ethnic fine-mapping studies reveal cell-type-specific expression pancreas-specific tcf7l2-null mice altered cis-regulatory elements genome-wide association identifies month download article/chapter human transcription factors combining genetic fine-mapping leveraging functional-annotation data statistical fine-mapping studies high-throughput epigenomics data genome-wide approach accounting phenome-wide association studies large-scale association analysis genome-wide association studies multitissue gene regulation body mass index characterize protein-dna interactions full article pdf transcription factor complexes fogarty mp mammalian genomes identified van de bunt genetic fine mapping transancestral fine-mapping open access resource cis-regulatory landscapes small effect variants manning fox je genetic regulatory signature lymphoid gene enhancers affect protein function klf14 locus related diabetes risk loci genome-wide associations ciliary gene vicinal expression qtl mapping van de geijn genetic association studies privacy choices/manage cookies t2dm risk loci diabetes risk locus human pancreatic islets muylti-ethnic samples pancreatic beta cell genome editing techniques locke ae

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Mechanisms of Type 2 Diabetes Risk Loci
         description:Deciphering the mechanisms of type 2 diabetes (T2DM) risk loci can greatly inform on disease pathology. This review discusses current knowledge of mechanisms through which genetic variants influence T2DM risk and considerations for future studies. Over 100 T2DM risk loci to date have been identified. Candidate causal variants at risk loci map predominantly to non-coding sequence. Physiological, epigenomic and gene expression data suggest that variants at many known T2DM risk loci affect pancreatic islet regulation, although variants at other loci also affect protein function and regulatory processes in adipose, pre-adipose, liver, skeletal muscle and brain. The effects of T2DM variants on regulatory activity in these tissues appear largely, but not exclusively, due to altered transcription factor binding. Putative target genes of T2DM variants have been defined at an increasing number of loci and some, such as FTO, may entail several genes and multiple tissues. Gene networks in islets and adipocytes have been implicated in T2DM risk, although the molecular pathways of risk genes remain largely undefined. Efforts to fully define the mechanisms of T2DM risk loci are just beginning. Continued identification of risk mechanisms will benefit from combining genetic fine-mapping with detailed phenotypic association data, high-throughput epigenomics data from diabetes-relevant tissue, functional screening of candidate genes and genome editing of cellular and animal models.
         datePublished:2017-07-24T00:00:00Z
         dateModified:2017-07-24T00:00:00Z
         pageStart:1
         pageEnd:10
         sameAs:https://doi.org/10.1007/s11892-017-0908-x
         keywords:
            Human genetics
            GWAS
            Physiology
            Epigenomics
            Gene regulation
            Diabetes
         image:
         isPartOf:
            name:Current Diabetes Reports
            issn:
               1539-0829
               1534-4827
            volumeNumber:17
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kyle J. Gaulton
               affiliation:
                     name:University of California San Diego
                     address:
                        name:Department of Pediatrics, University of California San Diego, San Diego, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Mechanisms of Type 2 Diabetes Risk Loci
      description:Deciphering the mechanisms of type 2 diabetes (T2DM) risk loci can greatly inform on disease pathology. This review discusses current knowledge of mechanisms through which genetic variants influence T2DM risk and considerations for future studies. Over 100 T2DM risk loci to date have been identified. Candidate causal variants at risk loci map predominantly to non-coding sequence. Physiological, epigenomic and gene expression data suggest that variants at many known T2DM risk loci affect pancreatic islet regulation, although variants at other loci also affect protein function and regulatory processes in adipose, pre-adipose, liver, skeletal muscle and brain. The effects of T2DM variants on regulatory activity in these tissues appear largely, but not exclusively, due to altered transcription factor binding. Putative target genes of T2DM variants have been defined at an increasing number of loci and some, such as FTO, may entail several genes and multiple tissues. Gene networks in islets and adipocytes have been implicated in T2DM risk, although the molecular pathways of risk genes remain largely undefined. Efforts to fully define the mechanisms of T2DM risk loci are just beginning. Continued identification of risk mechanisms will benefit from combining genetic fine-mapping with detailed phenotypic association data, high-throughput epigenomics data from diabetes-relevant tissue, functional screening of candidate genes and genome editing of cellular and animal models.
      datePublished:2017-07-24T00:00:00Z
      dateModified:2017-07-24T00:00:00Z
      pageStart:1
      pageEnd:10
      sameAs:https://doi.org/10.1007/s11892-017-0908-x
      keywords:
         Human genetics
         GWAS
         Physiology
         Epigenomics
         Gene regulation
         Diabetes
      image:
      isPartOf:
         name:Current Diabetes Reports
         issn:
            1539-0829
            1534-4827
         volumeNumber:17
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kyle J. Gaulton
            affiliation:
                  name:University of California San Diego
                  address:
                     name:Department of Pediatrics, University of California San Diego, San Diego, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Diabetes Reports
      issn:
         1539-0829
         1534-4827
      volumeNumber:17
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California San Diego
      address:
         name:Department of Pediatrics, University of California San Diego, San Diego, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kyle J. Gaulton
      affiliation:
            name:University of California San Diego
            address:
               name:Department of Pediatrics, University of California San Diego, San Diego, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pediatrics, University of California San Diego, San Diego, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(482)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.38s.

LINK . SPRINGER . COM {}